# ZPTA (Zapata Quantum, Inc.) - SEC EDGAR Financial Statements

> Zapata Quantum, Inc. reported $11.92M in total assets and a net loss of $1.90M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ZPTA
- Markdown: https://convexityos.com/fundamentals/ZPTA.md
- SEC CIK: 0001843714
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001843714&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$6.73M | Operating profit |
| Net Income | FY 2025 | -$1.90M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $11.24M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $3.88M | $5.68M | -- | -- |
| Cost of Revenue | -- | $3.24M | $4.58M | -- | -- |
| **Gross Profit** | -- | $635K | $1.10M | -- | -- |
| Research & Development | $252K | $4.42M | $5.92M | -- | -- |
| Selling, General & Admin | $3.17M | $19.26M | $13.29M | -- | -- |
| Total Operating Expenses | $3.43M | $23.68M | $19.21M | -- | -- |
| **Operating Income** | -$3.43M | -$23.05M | -$18.11M | -$1.51M | -$11K |
| **EBITDA** | -- | -$22.93M | -$17.94M | -- | -- |
| Interest Income | -- | -- | $8.16M | $3.40M | $0 |
| Interest Expense | $513K | $962K | $71K | $0 | -- |
| Income Before Tax | $9.34M | -$38.12M | -$29.71M | -- | -- |
| Income Tax Expense | -- | $20K | $20K | $0 | -- |
| **Net Income** | $9.34M | -$38.14M | -$29.73M | $1.89M | -$11K |
| Basic EPS | $0.09 | -$1.30 | -$5.82 | -- | -- |
| **Diluted EPS** | $0.04 | -$1.30 | -$5.82 | -- | -- |
| Basic Shares Outstanding | 101.9M | 29.4M | 4.7M | -- | -- |
| Diluted Shares Outstanding | 227.4M | 29.4M | 4.7M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $0 | -- | -- | -- | $0 | -- | $0 |
| Cost of Revenue | -- | $0 | -- | -- | -- | $0 | -- | $0 |
| **Gross Profit** | -- | $0 | -- | -- | -- | $0 | -- | $0 |
| Research & Development | $1.04M | $383K | $235K | -- | -- | $0 | -- | $42K |
| Selling, General & Admin | $1.74M | $1.24M | $962K | -- | $1.03M | $584K | -- | $2.94M |
| Total Operating Expenses | $2.78M | $1.63M | $1.20M | $1.13M | $1.03M | $584K | $680K | $2.98M |
| **Operating Income** | -$2.78M | -$1.63M | -$1.20M | -$1.13M | -$1.03M | -$584K | -$680K | -$2.98M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$2.97M |
| Interest Expense | -- | $229K | $132K | $134K | $136K | $141K | $102K | $45K |
| Income Before Tax | -- | -- | -$1.31M | $4.14M | $3.27M | $2.70M | -$770K | -$3.73M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | -$2.90M | -$1.83M | -$1.31M | $4.14M | $3.27M | $2.70M | -$770K | -$3.73M |
| Basic EPS | -$0.02 | -$0.01 | -$0.01 | -- | $0.03 | $0.05 | -$0.02 | -- |
| **Diluted EPS** | -$0.02 | -$0.01 | -$0.01 | -- | $0.02 | $0.04 | -$0.02 | -- |
| Basic Shares Outstanding | 189.8M | 186.2M | 172.3M | -- | 96.2M | 51.8M | 42.5M | -- |
| Diluted Shares Outstanding | 189.8M | 186.2M | 172.3M | -- | 214.8M | 66.3M | 42.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $38K | $2.69M | $0 | $0 |
| **Cash & Short-Term Investments** | $0 | $38K | $2.69M | $0 | $0 |
| Accounts Receivable, Net | -- | $1.57M | $829K | -- | -- |
| **Total Current Assets** | $1.84M | $2.18M | $5.59M | $1.21M | $2.0K |
| Property, Plant & Equipment, Net | -- | -- | $156K | -- | -- |
| Other Non-Current Assets | $432K | $550K | $137K | -- | -- |
| **Total Non-Current Assets** | $432K | $550K | $2.47M | $239.2M | $596K |
| **Total Assets** | $2.27M | $2.73M | $8.07M | $240.4M | $598K |
| Accounts Payable | $3.96M | $13.97M | $6.45M | -- | -- |
| Short-Term Debt | $4.41M | $1.62M | $0 | -- | -- |
| Deferred Revenue (Current) | $406K | $406K | $744K | $500K | -- |
| **Total Current Liabilities** | $10.54M | $23.66M | $9.39M | $115K | $584K |
| **Total Non-Current Liabilities** | $0 | $2.55M | $8.90M | $8.21M | $0 |
| **Total Liabilities** | $10.54M | $26.21M | $18.29M | $8.33M | $584K |
| **Total Debt (incl. Leases)** | $4.41M | $4.17M | $9.15M | -- | -- |
| Common Stock | $17K | $4.0K | $0 | -- | -- |
| Retained Earnings | -$118.3M | -$127.7M | -$89.53M | -$7.09M | -$11K |
| Accumulated Other Comp. Income | -$162K | -$109K | -$49K | -- | -- |
| **Total Stockholders' Equity** | -$8.27M | -$23.47M | -$10.23M | -$57.08M | $14K |
| Total Equity | -$8.27M | -$23.47M | -$10.23M | -$57.08M | $14K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.24M | $12.77M | $642K | $0 | $919K | $1.36M | $288K | $38K |
| **Cash & Short-Term Investments** | $11.24M | $12.77M | $642K | $0 | $919K | $1.36M | $288K | $38K |
| Accounts Receivable, Net | -- | -- | -- | -- | $1.59M | $1.59M | $1.59M | $1.57M |
| **Total Current Assets** | $11.53M | $12.96M | $800K | $1.84M | $2.84M | $3.27M | $2.05M | $2.18M |
| Other Non-Current Assets | $386K | $385K | $404K | $432K | $464K | $493K | $521K | $550K |
| **Total Non-Current Assets** | $386K | $385K | $404K | $432K | $464K | $493K | $521K | $550K |
| **Total Assets** | $11.92M | $13.34M | $1.20M | $2.27M | $3.30M | $3.77M | $2.57M | $2.73M |
| Accounts Payable | $3.95M | $3.75M | $4.07M | $3.96M | $12.24M | $13.93M | $14.02M | $13.97M |
| Short-Term Debt | -- | -- | -- | $4.41M | $3.04M | $2.84M | $1.93M | $1.62M |
| Deferred Revenue (Current) | -- | -- | $406K | $406K | $406K | $406K | $406K | $406K |
| **Total Current Liabilities** | -- | -- | -- | $10.54M | $18.12M | $21.94M | $24.47M | $23.66M |
| **Total Non-Current Liabilities** | -- | -- | -- | $0 | $1.23M | $1.20M | $2.31M | $2.55M |
| **Total Liabilities** | $10.39M | $10.28M | $10.56M | $10.54M | $19.36M | $23.13M | $26.78M | $26.21M |
| **Total Debt (incl. Leases)** | -- | -- | $4.54M | $4.41M | $4.27M | $4.04M | $4.24M | $4.17M |
| Common Stock | $19K | $19K | $17K | $17K | $10K | $9.0K | $4.0K | $4.0K |
| Retained Earnings | -$124.9M | -$121.7M | -$119.6M | -$118.3M | -$122.5M | -$125.7M | -$128.4M | -$127.7M |
| Accumulated Other Comp. Income | -$220K | -$201K | -$180K | -$162K | -$143K | -$131K | -$123K | -$109K |
| **Total Stockholders' Equity** | $1.53M | $3.06M | -$9.36M | -$8.27M | -$16.06M | -$19.36M | -$24.21M | -$23.47M |
| Total Equity | $1.53M | $3.06M | -$9.36M | -$8.27M | -$16.06M | -$19.36M | -$24.21M | -$23.47M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | $9.37M | -$38.14M | -$29.73M | $1.89M | -$11K |
| Depreciation & Amortization | -- | $118K | $164K | -- | -- |
| Stock-Based Compensation | $26K | $0 | $776K | -- | -- |
| Change in Receivables | -- | -$90K | -$510K | -- | -- |
| Change in Payables | $198K | $7.06M | $3.51M | -- | -- |
| **Operating Cash Flow** | -$1.67M | -$18.11M | -$14.76M | -$1.93M | -$7.9K |
| Capital Expenditure | -- | -$34K | -- | -- | -- |
| **Free Cash Flow** | -- | -$18.14M | -- | -- | -- |
| **Investing Cash Flow** | -- | -$34K | $161.0M | -$235.8M | $0 |
| Common Stock Issued | -- | -- | $0 | $6.2K | $0 |
| Share Repurchases | -- | -- | -$161.0M | -- | -- |
| **Financing Cash Flow** | $3.02M | $15.10M | $8.04M | $238.3M | $7.9K |
| **Net Change in Cash** | $1.30M | -$3.11M | -$6.74M | $616K | $0 |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.90M | -$1.83M | -$1.31M | $4.17M | $3.27M | $2.70M | -$770K | -$3.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $9.0K |
| Stock-Based Compensation | $1.09M | $206K | $238K | -$90K | $42K | $30K | $44K | -$58K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | -$47K |
| Change in Payables | $204K | -$321K | $107K | -$8.0K | $132K | $26K | $48K | $449K |
| **Operating Cash Flow** | -$1.80M | -$1.69M | -$999K | -$680K | -$521K | -$405K | -$59K | -$3.01M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$3.01M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $149K |
| **Net Change in Cash** | -$1.53M | $12.13M | -$1.02M | $740K | -$437K | $1.07M | -$71K | -$2.88M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 16.4% | 19.4% | -- | -- |
| **Operating Margin** | -- | -594.6% | -318.6% | -- | -- |
| **Net Profit Margin** | -- | -984.1% | -523.2% | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | -76.8% |
| Return on Assets (ROA) | 410.9% | -1395.6% | -368.6% | 0.8% | -1.8% |
| Current Ratio | 0.17x | 0.09x | 0.60x | 10.46x | 0.00x |
| Quick Ratio | 0.00x | 0.07x | 0.37x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -- | -31.8% | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -42.3% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -1673.0% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 16.3% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -594.6% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -984.1% |
| Return on Equity (ROE) | -124.4% | 139.2% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -15.9% | 31.9% | 730.6% | 410.9% | 44.4% | 44.7% | -646.1% | -1395.6% |
| Current Ratio | -- | -- | -- | 0.17x | 0.16x | 0.15x | 0.08x | 0.09x |
| Quick Ratio | -- | -- | -- | 0.00x | 0.14x | 0.13x | 0.08x | 0.07x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| **Net Income Growth (YoY)** | -188.7% | -168.0% | -- | -- | -6.2% | -- | -- | -- |
| EPS Growth (YoY) | -166.7% | -120.0% | -- | -- | -66.7% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
